Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared a post by PER on X, adding:
“Tremendous, fun, informative symposium on ADCs across breast cancer types and stages.
Such a pleasure to join this along G Curiglianoand and Alastair Thompson – moderated by Hope Rugo. ”
Quoting PER’s post:
“Coffee Talk: Charting New Pathways with HER2 and TROP2 Therapies – From Early to Advanced Breast Cancer.”
Proceed to the video attached to the post.
Other articles featuring Paolo Tarantino.